
Mandrake Bioworks makes new proteins faster by combining AI with structural biology. It uses AI-powered design tools and structural prediction to create de novo proteins for research and development. The company targets biotech and pharmaceutical labs that need custom proteins for enzymes, therapeutics, or catalysts. The platform integrates with common lab workflows and data pipelines to streamline design, testing, and iteration. As the protein design market grows, Mandrake Bioworks plans to scale across biopharma and academic research.

Mandrake Bioworks makes new proteins faster by combining AI with structural biology. It uses AI-powered design tools and structural prediction to create de novo proteins for research and development. The company targets biotech and pharmaceutical labs that need custom proteins for enzymes, therapeutics, or catalysts. The platform integrates with common lab workflows and data pipelines to streamline design, testing, and iteration. As the protein design market grows, Mandrake Bioworks plans to scale across biopharma and academic research.